Lifesci Acquisition Corp (LSAC)


Stock Price Forecast

Dec. 23, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Lifesci Acquisition Corp chart...

About the Company

We do not have any company description for Lifesci Acquisition Corp at the moment.

Exchange

NASDAQ CAPITAL MARKET

$M

Total Revenue

None

Employees

$152M

Market Capitalization

-271.43

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LSAC News

LifeSci Acquisition II

3y ago, source: Wall Street Journal

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Buy Rating Affirmed for Vincerx Pharma Ahead of AACR Presentation: Promising Developments in Oncology Drug Pipeline

21d ago, source: Business Insider

Vincerx Pharma Inc (VINC) Company Description: LifeSci Acquisition Corp is a blank check company. Read More on VINC: Vincera Pharma NewsMORE Related Stocks Indices ...

Jonas Grossman's Net Worth

7d ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include Presto Automation Inc., cleantech Acquisition Corp., CHINA BROADBAND INC, Dragonfly Energy Holdings Corp., LifeSci ...

Andrew I McDonald's Net Worth

14d ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include Lifesci Acquisition II Corp., and Vincerx Pharma, Inc.. Attention insiders: Dive deeper into market movements and stay ...

Edify Acquisition Corp. to Liquidate

22d ago, source: Yahoo Finance

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Edify Acquisition Corp. (NASDAQ: EAC) (the “Company”) announced that the Company and Unique Logistics International, Inc. (“UNQL”) have ...

Humacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call Transcript

5d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call Transcript March 22, 2024 Humacyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at ...

Plutonian Acquisition Corp Ordinary Shares PLTN

1d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Arogo Capital Acquisition Corp. Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

18d ago, source: Yahoo Finance

Arogo Capital Acquisition Corp. is a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase ...

Analysts’ Top Healthcare Picks: Argenx Se (ARGX), MoonLake Immunotherapeutics (MLTX)

13d ago, source: Business Insider

In a report issued on February 29, LifeSci Capital also maintained a Buy rating on the stock with a $75.00 price target. TipRanks has tracked 36,000 company insiders and ... their insider activities.

XPDB Power & Digital Infrastructure Acquisition II Corp.

15h ago, source: Seeking Alpha

As of March 14, 2024, Power & Digital Infrastructure Acquisition II Corp. was acquired by Montana Technologies LLC, in a reverse merger transaction. Power & Digital Infrastructure Acquisition II ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...